[1]Patent:WO2005/16883,2005,A2.Locationinpatent:Page/Pagecolumn264
[1]Patent:US9562069,2017,B2
185379-39-9
282734-37-6
185379-40-2
1690821-45-4
1379859-26-3
1998643-85-8
223652-90-2 | Garenoxacin mesylate hydrate | AA00BF38 | MFCD12031996
290832-31-4 | 3-(5-FLUORO-2-PHENYL-1H-INDOL-3-YL)PROPANOIC ACID | AA00BF8C | MFCD06660845
219310-10-8 | L-Beta-homoisoleucine, HCl | AA00BFEM | MFCD01862849
29884-49-9 | TRANS-ASTRINGIN | AA00BFP7 | MFCD03427331
24078-24-8 | Methyl 4-formyl-3-methylbenzoate | AA00BG2Q | MFCD20923636
27252-87-5 | Poly(oxy-1,2-ethanediyl), .alpha.-acetyl-.omega.-(2-propenyloxy)- | AA00BGH0
303987-90-8 | Methyl 4-methyl-3-oxo-3,4-dihydro-2h-1,4-benzothiazine-6-carboxylate | AA00BGVR | MFCD01569173
25616-02-8 | Boc-his(1-boc)-osu | AA00BH4V | MFCD00236852
2140-71-8 | 2'-O-Methylguanosine | AA00BHIM | MFCD00057053
284664-59-1 | 2-Chloro-6-methyl-3-phenylquinoline | AA00BHXA | MFCD00126763